InsiderTrades.com logo

ACAD Insider Trading

Insider Ownership Percentage: 26.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $2,504,885.14

ACADIA Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at ACADIA Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ACADIA Pharmaceuticals Share Price & Price History

Current Price: $20.99
Price Change: ▲ Price Increase of +0.25 (1.21%)
As of 03/23/2026 05:00 PM ET

This chart shows the closing price history over time for ACAD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

ACADIA Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/9/2026Jennifer J. RhodesEVPSell6,950$23.38$162,491.007,609View SEC Filing Icon  
11/18/2025James KiharaInsiderSell4,084$23.69$96,749.9625,058View SEC Filing Icon  
11/18/2025Mark C. SchneyerEVPSell10,262$23.69$243,106.7853,338View SEC Filing Icon  
11/10/2025James M. DalyDirectorSell30,000$22.37$671,100.004,041View SEC Filing Icon  
9/15/2025Mark C. SchneyerEVPSell3,498$23.65$82,727.7043,447View SEC Filing Icon  
9/2/2025Elizabeth A GarofaloDirectorSell1,600$25.98$41,568.0025,382View SEC Filing Icon  
8/18/2025Mark C. SchneyerEVPSell22,000$25.18$553,960.0040,130View SEC Filing Icon  
6/4/2025Laura BregeDirectorSell14,446$21.78$314,633.8815,095View SEC Filing Icon  
5/16/2025James KiharaInsiderSell4,000$22.50$90,000.0020,395View SEC Filing Icon  
5/16/2025Mark C. SchneyerEVPSell2,000$25.00$50,000.0062,130View SEC Filing Icon  
5/2/2025James KiharaInsiderSell1,327$14.60$19,374.2023,526View SEC Filing Icon  
5/2/2025Mark C. SchneyerEVPSell3,498$14.60$51,070.8062,773View SEC Filing Icon  
4/8/2025James KiharaInsiderSell1,028$14.82$15,234.9622,257View SEC Filing Icon  
4/8/2025Mark C. SchneyerEVPSell2,708$14.82$40,132.5659,456View SEC Filing Icon  
3/26/2025James KiharaInsiderSell1,095$17.05$18,669.7521,275View SEC Filing Icon  
3/26/2025Mark C. SchneyerEVPSell3,171$17.05$54,065.5556,889View SEC Filing Icon  
3/5/2025Elizabeth A GarofaloDirectorSell4,919$18.23$89,673.3717,595View SEC Filing Icon  
2/24/2025James KiharaInsiderSell475$19.96$9,481.0020,228View SEC Filing Icon  
2/24/2025Mark C. SchneyerCFOSell773$19.96$15,429.0853,882View SEC Filing Icon  
11/19/2024Brendan TeehanCOOSell10,329$16.81$173,630.4962,105View SEC Filing Icon  
11/19/2024James KiharaInsiderSell4,073$16.81$68,467.1319,863View SEC Filing Icon  
11/19/2024Mark C. SchneyerCFOSell10,259$16.81$172,453.7953,302View SEC Filing Icon  
8/19/2024Brendan TeehanCOOSell9,534$15.28$145,679.5252,177View SEC Filing Icon  
8/19/2024Mark C. SchneyerCFOSell9,733$15.28$148,720.2443,735View SEC Filing Icon  
8/19/2024Stephen R. DavisCEOSell31,747$15.28$485,094.16186,555View SEC Filing Icon  
6/10/2024Mark C. SchneyerCFOSell975$14.79$14,420.2534,564View SEC Filing Icon  
5/2/2024Brendan TeehanCOOSell3,477$16.94$58,900.3842,133View SEC Filing Icon  
5/2/2024James KiharaInsiderSell1,326$16.94$22,462.4414,370View SEC Filing Icon  
5/2/2024Mark C. SchneyerCFOSell3,503$16.94$59,340.8232,053View SEC Filing Icon  
5/2/2024Stephen R. DavisCEOSell11,427$16.94$193,573.38155,231View SEC Filing Icon  
4/8/2024Brendan TeehanCOOSell2,568$17.87$45,890.1638,796View SEC Filing Icon  
4/8/2024James KiharaInsiderSell1,790$17.87$31,987.3013,100View SEC Filing Icon  
4/8/2024Mark C. SchneyerCFOSell2,716$17.87$48,534.9228,742View SEC Filing Icon  
4/8/2024Stephen R. DavisCEOSell26,574$17.87$474,877.38144,267View SEC Filing Icon  
3/27/2024Brendan TeehanCOOSell5,140$17.90$92,006.0036,340View SEC Filing Icon  
3/27/2024Mark C. SchneyerCFOSell5,434$17.90$97,268.6026,183View SEC Filing Icon  
3/27/2024Stephen R. DavisCEOSell17,714$17.90$317,080.60118,842View SEC Filing Icon  
2/26/2024Brendan TeehanCOOSell624$24.67$15,394.0831,432View SEC Filing Icon  
2/26/2024James KiharaInsiderSell474$24.67$11,693.5811,391View SEC Filing Icon  
2/26/2024Mark C. SchneyerCFOSell772$24.67$19,045.2421,067View SEC Filing Icon  
2/26/2024Stephen R. DavisCEOSell5,577$24.67$137,584.59101,890View SEC Filing Icon  
1/8/2024Austin D KimEVPSell590$29.96$17,676.4046,901View SEC Filing Icon  
1/8/2024Brendan TeehanCOOSell731$29.96$21,900.7630,949View SEC Filing Icon  
1/8/2024Stephen R. DavisCEOSell3,732$29.96$111,810.7296,521View SEC Filing Icon  
12/15/2023James KiharaInsiderSell2,000$28.30$56,600.0011,025View SEC Filing Icon  
11/20/2023Brendan TeehanCOOSell4,960$22.64$112,294.4030,393View SEC Filing Icon  
11/20/2023James KiharaInsiderSell1,985$22.64$44,940.4013,025View SEC Filing Icon  
11/20/2023Mark C. SchneyerCFOSell5,108$22.64$115,645.1220,486View SEC Filing Icon  
10/6/2023Austin D KimEVPSell16,369$21.96$359,463.2445,857View SEC Filing Icon  
10/6/2023Stephen R. DavisCEOSell51,563$21.96$1,132,323.4889,131View SEC Filing Icon  
9/15/2023James KiharaInsiderSell2,000$25.88$51,760.0010,778View SEC Filing Icon  
8/21/2023Mark C. SchneyerCFOSell10,000$29.00$290,000.0015,682View SEC Filing Icon  
7/14/2023Stephen R. DavisCEOSell100,000$30.04$3,004,000.0036,695View SEC Filing Icon  
7/11/2023Stephen R. DavisCEOSell16,498$25.00$412,450.0091,799View SEC Filing Icon  
6/15/2023James KiharaInsiderSell2,000$24.15$48,300.009,144View SEC Filing Icon  
6/12/2023Laura BregeDirectorSell4,500$24.87$111,915.0013,502View SEC Filing Icon  
6/8/2023Mark C. SchneyerCFOSell974$25.02$24,369.4822,824View SEC Filing Icon  
5/23/2023Bros. Advisors Lp BakerDirectorBuy209,053$25.41$5,312,036.7338,811,515View SEC Filing Icon  
5/17/2023Brendan TeehanCOOSell14,869$22.50$334,552.5024,356View SEC Filing Icon  
5/17/2023James KiharaInsiderSell5,947$22.50$133,807.5011,144View SEC Filing Icon  
5/17/2023Mark C. SchneyerCFOSell15,310$22.50$344,475.0021,905View SEC Filing Icon  
5/1/2023Austin D KimEVPSell917$21.18$19,422.0625,513View SEC Filing Icon  
5/1/2023Brendan TeehanCOOSell548$21.18$11,606.649,487View SEC Filing Icon  
5/1/2023Stephen R. DavisCEOSell7,806$21.18$165,331.08108,297View SEC Filing Icon  
4/10/2023James KiharaInsiderSell523$18.14$9,487.225,197View SEC Filing Icon  
4/6/2023Austin D KimEVPSell1,456$18.16$26,440.9623,425View SEC Filing Icon  
4/6/2023Brendan TeehanCOOSell1,751$18.16$31,798.168,468View SEC Filing Icon  
4/6/2023James KiharaInsiderSell701$18.16$12,730.164,231View SEC Filing Icon  
4/6/2023Mark C. SchneyerCFOSell1,916$18.16$34,794.567,477View SEC Filing Icon  
4/6/2023Stephen R. DavisCEOSell8,582$18.16$155,849.12100,478View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for ACADIA Pharmaceuticals (NASDAQ:ACAD)

96.71% of ACADIA Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ACAD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

ACADIA Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/20/2026Hsbc Holdings PLC26,286$0.70M0.0%-14.6%0.015%Search for SEC Filing on Google Icon
3/17/2026Rockefeller Capital Management L.P.1,113,040$29.73M0.1%+7.4%0.653%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.847,961$22.65M0.0%+14.5%0.501%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV9,620$0.26M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/18/2026State of Tennessee Department of Treasury49,505$1.24M0.0%-8.5%0.029%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp57,274$1.53M0.0%+7.3%0.034%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC25,170$0.67M0.2%+23.1%0.015%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP53,289$1.42M0.0%-3.7%0.031%Search for SEC Filing on Google Icon
2/18/2026Tang Capital Management LLC300,000$8.01M0.4%-80.0%0.177%Search for SEC Filing on Google Icon
2/18/2026Sphera Funds Management LTD.212,202$5.67M1.1%+42.5%0.125%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC553,674$14.79M0.0%-62.7%0.327%Search for SEC Filing on Google Icon
2/18/2026Man Group plc348,160$9.30M0.0%-7.7%0.206%Search for SEC Filing on Google Icon
2/18/2026Ishara Investments LP160,000$4.27M4.9%N/A0.095%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC290,111$7.75M0.0%+464.3%0.171%Search for SEC Filing on Google Icon
2/18/2026Gotham Asset Management LLC18,441$0.49M0.0%-57.3%0.011%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP73,840$1.97M0.0%+24.1%0.044%Search for SEC Filing on Google Icon
2/18/2026Eversept Partners LP176,594$4.72M0.2%+7.5%0.104%Search for SEC Filing on Google Icon
2/17/2026Guggenheim Capital LLC94,687$2.53M0.0%+194.8%0.056%Search for SEC Filing on Google Icon
2/17/2026Logos Global Management LP850,000$22.70M1.4%N/A0.502%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC604,748$16.15M0.0%-2.6%0.357%Search for SEC Filing on Google Icon
2/17/2026Braidwell LP2,032,021$54.28M1.7%-14.6%1.201%Search for SEC Filing on Google Icon
2/17/2026Abel Hall LLC10,073$0.27M0.1%N/A0.006%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers16,355$0.44M0.0%+2.7%0.010%Search for SEC Filing on Google Icon
2/17/2026Lazard Asset Management LLC226,222$6.04M0.0%+30.9%0.134%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP297,802$7.95M0.1%+30.6%0.176%Search for SEC Filing on Google Icon
2/17/2026Amundi18,245$0.49M0.0%-18.7%0.011%Search for SEC Filing on Google Icon
2/17/2026Jump Financial LLC108,355$2.89M0.0%N/A0.064%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD615,169$16.43M0.0%-44.1%0.364%Search for SEC Filing on Google Icon
2/17/2026Osaic Holdings Inc.9,918$0.27M0.0%-41.8%0.006%Search for SEC Filing on Google Icon
2/17/2026Weiss Asset Management LP58,740$1.57M0.0%N/A0.035%Search for SEC Filing on Google Icon
2/17/2026Adage Capital Partners GP L.L.C.9,156$0.25M0.0%-99.6%0.005%Search for SEC Filing on Google Icon
2/17/2026California State Teachers Retirement System126,807$3.39M0.0%+25.9%0.075%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.138,296$3.69M0.0%+75.1%0.082%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board150,386$4.02M0.0%-20.5%0.089%Search for SEC Filing on Google Icon
2/17/2026Captrust Financial Advisors8,245$0.22M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/17/2026Fred Alger Management LLC1,559,962$41.67M0.2%-0.5%0.922%Search for SEC Filing on Google Icon
2/17/2026ExodusPoint Capital Management LP76,183$2.04M0.0%N/A0.045%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada290,854$7.77M0.0%-67.7%0.172%Search for SEC Filing on Google Icon
2/17/2026Rice Hall James & Associates LLC603,740$16.13M0.9%-1.8%0.357%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC40,709$1.09M0.0%N/A0.024%Search for SEC Filing on Google Icon
2/16/2026Sofinnova Investments Inc.65,567$1.75M0.1%+144.7%0.039%Search for SEC Filing on Google Icon
2/16/2026Panagora Asset Management Inc.681,102$18.19M0.1%+3.7%0.403%Search for SEC Filing on Google Icon
2/16/2026MML Investors Services LLC32,737$0.87M0.0%+46.7%0.019%Search for SEC Filing on Google Icon
2/16/2026Mariner LLC24,157$0.65M0.0%+65.0%0.014%Search for SEC Filing on Google Icon
2/16/2026Frazier Life Sciences Management L.P.1,297,198$34.65M0.9%+111.3%0.767%Search for SEC Filing on Google Icon
2/16/2026Garrison Point Advisors LLC9,501$0.25M0.1%-10.2%0.006%Search for SEC Filing on Google Icon
2/16/2026Entropy Technologies LP12,796$0.34M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/16/2026Avidity Partners Management LP106,900$2.86M0.8%-25.8%0.063%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC368,304$9.84M0.0%-15.3%0.218%Search for SEC Filing on Google Icon
2/13/2026Arete Wealth Advisors LLC11,500$0.31M0.0%-15.6%0.007%Search for SEC Filing on Google Icon
2/13/2026Kestra Advisory Services LLC4,395$0.12M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/13/2026Transamerica Financial Advisors LLC1,335$36K0.0%+304.5%0.001%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP493,379$13.18M0.0%-79.1%0.292%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 532,533$14.22M0.0%-0.3%0.315%Search for SEC Filing on Google Icon
2/13/2026CANADA LIFE ASSURANCE Co106,969$2.86M0.0%-13.2%0.063%Search for SEC Filing on Google Icon
2/13/2026Segall Bryant & Hamill LLC126,066$3.37M0.0%N/A0.075%Search for SEC Filing on Google Icon
2/13/2026Bridgewater Associates LP138,179$3.69M0.0%-15.4%0.082%Search for SEC Filing on Google Icon
2/13/2026Stifel Financial Corp12,840$0.34M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/13/2026Quarry LP16,000$0.43M0.1%+40.6%0.009%Search for SEC Filing on Google Icon
2/13/2026Smartleaf Asset Management LLC2,596$69K0.0%+51.6%0.002%Search for SEC Filing on Google Icon
2/13/2026Advyzon Investment Management LLC11,612$0.31M0.0%+7.4%0.007%Search for SEC Filing on Google Icon
2/13/2026Jacobs Levy Equity Management Inc.371,047$9.91M0.0%-50.0%0.219%Search for SEC Filing on Google Icon
2/13/2026Public Sector Pension Investment Board433,247$11.57M0.0%-11.0%0.256%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC198,263$5.30M0.0%+1.7%0.117%Search for SEC Filing on Google Icon
2/13/2026First Trust Advisors LP2,270,034$60.63M0.0%+16.8%1.342%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.1,172,317$31.31M0.0%-2.6%0.693%Search for SEC Filing on Google Icon
2/13/2026State Street Corp7,910,733$211.30M0.0%+9.0%4.676%Search for SEC Filing on Google Icon
2/13/2026Ieq Capital LLC82,344$2.20M0.0%+12.1%0.049%Search for SEC Filing on Google Icon
2/13/2026Martingale Asset Management L P109,319$2.92M0.1%+9.0%0.065%Search for SEC Filing on Google Icon
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC205,433$5.49M0.0%-2.7%0.121%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN209,188$5.59M0.0%+38.7%0.124%Search for SEC Filing on Google Icon
2/12/2026Advisors Asset Management Inc.8,769$0.23M0.0%-35.7%0.005%Search for SEC Filing on Google Icon
2/12/2026Hollencrest Capital Management3,000$80K0.0%-53.8%0.002%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC70,465$1.88M0.0%-4.9%0.042%Search for SEC Filing on Google Icon
2/12/2026Cibc World Markets Corp8,234$0.22M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/12/2026Commonwealth Equity Services LLC14,705$0.39M0.0%+7.3%0.009%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC1,532,596$40.94M0.1%+5.7%0.906%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP2,920,974$78.02M0.0%+4.4%1.727%Search for SEC Filing on Google Icon
2/12/2026Federated Hermes Inc.1,612$43K0.0%+277.5%0.001%Search for SEC Filing on Google Icon
2/12/2026Ensign Peak Advisors Inc7,900$0.21M0.0%-66.9%0.005%Search for SEC Filing on Google Icon
2/12/2026New York State Common Retirement Fund52,070$1.39M0.0%-6.8%0.031%Search for SEC Filing on Google Icon
2/12/2026Bank of Montreal Can27,421$0.73M0.0%+16.5%0.016%Search for SEC Filing on Google Icon
2/12/2026Alps Advisors Inc.158,197$4.23M0.0%+58.5%0.094%Search for SEC Filing on Google Icon
2/12/2026Swiss National Bank232,904$6.22M0.0%+2.6%0.138%Search for SEC Filing on Google Icon
2/12/2026Great Lakes Advisors LLC313,536$8.38M0.1%-31.1%0.185%Search for SEC Filing on Google Icon
2/12/2026Aviva PLC19,311$0.52M0.0%-4.7%0.011%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC1,057,527$28.25M0.0%+10.9%0.625%Search for SEC Filing on Google Icon
2/11/2026Stirlingshire Investments Inc.10,619$0.28M0.3%N/A0.006%Search for SEC Filing on Google Icon
2/11/2026Meeder Asset Management Inc.984$26K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/11/2026Illinois Municipal Retirement Fund63,187$1.69M0.0%-10.6%0.037%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG828,594$22.13M0.0%-45.6%0.490%Search for SEC Filing on Google Icon
2/11/2026Fox Run Management L.L.C.10,552$0.28M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/11/2026Cerity Partners LLC27,729$0.74M0.0%-19.8%0.016%Search for SEC Filing on Google Icon
2/11/2026LPL Financial LLC40,152$1.07M0.0%+11.9%0.024%Search for SEC Filing on Google Icon
2/11/2026Franklin Resources Inc.171,483$4.58M0.0%-54.7%0.101%Search for SEC Filing on Google Icon
2/11/2026JPMorgan Chase & Co.270,826$7.23M0.0%-16.9%0.160%Search for SEC Filing on Google Icon
2/11/2026Los Angeles Capital Management LLC49,796$1.33M0.0%-22.1%0.029%Search for SEC Filing on Google Icon
2/11/2026Arrowpoint Investment Partners Singapore Pte. Ltd.10,011$0.27M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/11/2026J.W. Cole Advisors Inc.20,632$0.55M0.0%+2.5%0.012%Search for SEC Filing on Google Icon
2/11/2026Globeflex Capital L P7,536$0.20M0.0%N/A0.004%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
ACADIA Pharmaceuticals logo
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases in the United States. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome. It also develops Pimavanserin that is in Phase III ADVANCE-2 study to treat the negative symptoms of schizophrenia; ACP-101 whixh is in Phase III for the treatment of hyperphagia in Prader-Willi syndrome; ACP-204 which is in Phase II for the treatment of Alzheimer's disease psychosis; ACP-2591 that is in Phase I for Rett syndrome and Fragile X syndrome; preclinical antisense oligonucleotide programs; and other programs for neuropsychiatric symptoms. It has a license agreement with Neuren Pharmaceuticals Limited to develop and commercialize trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. ACADIA Pharmaceuticals Inc. was incorporated in 1993 and is headquartered in San Diego, California.
Read More on ACADIA Pharmaceuticals

Today's Range

Now: $20.99
Low: $20.94
High: $21.51

50 Day Range

MA: $23.92
Low: $20.32
High: $27.51

52 Week Range

Now: $20.99
Low: $13.40
High: $28.35

Volume

1,414,578 shs

Average Volume

1,657,867 shs

Market Capitalization

$3.58 billion

P/E Ratio

9.17

Dividend Yield

N/A

Beta

0.66

Who are the company insiders with the largest holdings of ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals' top insider investors include:
  1. Stephen Davis (CEO)
  2. Mark C Schneyer (EVP)
  3. Brendan Teehan (COO)
  4. Mark C Schneyer (CFO)
  5. Elizabeth A Garofalo (Director)
  6. James Kihara (Insider)
  7. Laura Brege (Director)
  8. Jennifer J Rhodes (EVP)
  9. James M Daly (Director)
Learn More about top insider investors at ACADIA Pharmaceuticals.

Who are the major institutional investors of ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals' top institutional shareholders include:
  1. Vanguard Group Inc. — 8.96%
  2. State Street Corp — 4.68%
  3. Geode Capital Management LLC — 1.91%
  4. Dimensional Fund Advisors LP — 1.73%
  5. First Trust Advisors LP — 1.34%
  6. Braidwell LP — 1.20%
Learn More about top institutional investors of ACADIA Pharmaceuticals stock.

Which institutional investors are selling ACADIA Pharmaceuticals stock?

In the last quarter, ACAD stock was sold by these institutional investors:
  1. Adage Capital Partners GP L.L.C.
  2. Marshall Wace LLP
  3. Tang Capital Management LLC
  4. Millennium Management LLC
  5. Deutsche Bank AG
  6. Royal Bank of Canada
  7. Goldman Sachs Group Inc.
  8. Price T Rowe Associates Inc. MD
During the previous year, company insiders that have sold ACADIA Pharmaceuticals company stock include:
  1. Stephen Davis (CEO)
  2. Mark C Schneyer (EVP)
  3. Brendan Teehan (COO)
  4. Mark C Schneyer (CFO)
  5. Elizabeth A Garofalo (Director)
  6. James Kihara (Insider)
Learn More investors selling ACADIA Pharmaceuticals stock.

Which institutional investors are buying ACADIA Pharmaceuticals stock?

During the previous quarter, ACAD stock was purchased by institutional investors including:
  1. Norges Bank
  2. Logos Global Management LP
  3. Frazier Life Sciences Management L.P.
  4. State Street Corp
  5. First Trust Advisors LP
  6. Janus Henderson Group PLC
  7. F m Investments LLC
  8. Ishara Investments LP